Susquehanna International Group’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-59,168
| Closed | -$286K | – | 11421 |
|
|
2020
Q1 | $286K | Buy |
59,168
+34,245
| +137% | +$222K | ﹤0.01% | 8078 |
|
|
2019
Q4 | $265K | Sell |
24,923
-33,869
| -58% | -$336K | ﹤0.01% | 8252 |
|
|
2019
Q3 | $612K | Buy |
58,792
+14,051
| +31% | +$184K | ﹤0.01% | 6815 |
|
|
2019
Q2 | $685K | Buy |
+44,741
| New | +$647K | ﹤0.01% | 6566 |
|
|
2019
Q1 | – | Sell |
-195,237
| Closed | -$2.21M | – | 10324 |
|
|
2018
Q4 | $1.85M | Buy |
195,237
+125,186
| +179% | +$1.62M | ﹤0.01% | 3633 |
|
|
2018
Q3 | $1.16M | Buy |
70,051
+25,286
| +56% | +$405K | ﹤0.01% | 4928 |
|
|
2018
Q2 | $718K | Buy |
+44,765
| New | +$799K | ﹤0.01% | 6083 |
|
|
2018
Q1 | – | Sell |
-36,579
| Closed | -$570K | – | 10598 |
|
|
2017
Q4 | $571K | Buy |
36,579
+10,665
| +41% | +$143K | ﹤0.01% | 6392 |
|
|
2017
Q3 | $288K | Buy |
+25,914
| New | +$244K | ﹤0.01% | 7477 |
|
|
2017
Q2 | – | Sell |
-75,746
| Closed | -$632K | – | 10138 |
|
|
2017
Q1 | $648K | Buy |
75,746
+6,824
| +10% | +$62.2K | ﹤0.01% | 6003 |
|
|
2016
Q4 | $737K | Buy |
+68,922
| New | +$834K | ﹤0.01% | 6166 |
|
|
2016
Q2 | – | Sell |
-44,988
| Closed | -$210K | – | 9660 |
|
|
2016
Q1 | $210K | Buy |
44,988
+33,685
| +298% | +$165K | ﹤0.01% | 7887 |
|
|
2015
Q4 | $71K | Sell |
11,303
-21,202
| -65% | -$172K | ﹤0.01% | 9013 |
|
|
2015
Q3 | $287K | Buy |
32,505
+19,072
| +142% | +$200K | ﹤0.01% | 8114 |
|
|
2015
Q2 | $158K | Buy |
13,433
+1,683
| +14% | +$23.4K | ﹤0.01% | 9466 |
|
|
2015
Q1 | $170K | Sell |
11,750
-578
| -5% | -$8.85K | ﹤0.01% | 8746 |
|
|
2014
Q4 | $210K | Sell |
12,328
-6,815
| -36% | -$98.3K | ﹤0.01% | 8748 |
|
|
2014
Q3 | $239K | Buy |
+19,143
| New | +$236K | ﹤0.01% | 8375 |
|
|
2014
Q1 | – | Sell |
-10,568
| Closed | -$207K | – | 9635 |
|
|
2013
Q4 | $207K | Buy |
+10,568
| New | +$282K | ﹤0.01% | 8215 |
|
Susquehanna International Group's STML Position: Q2 2020 in Review
Susquehanna International Group sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 59,168 shares — an estimated $286K sold.
Susquehanna International Group first reported a position in STML in Q4 2013 and held it in 19 quarters. The position peaked at $1.85M in Q4 2018. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- Susquehanna International Group reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- Susquehanna International Group sold 59,168 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $286K.
- Susquehanna International Group first reported a position in Stemline Therapeutics, Inc. in Q4 2013 and held it in 19 quarters.
- Susquehanna International Group's Stemline Therapeutics, Inc. position peaked at $1.85M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.